Report Highlights
The global cell and tissue analysis market should reach $28.9 billion by 2027 from $18.2 billion in 2022 at a compound annual growth rate (CAGR) of 9.6% for the forecast period of 2022 to 2027.
Report Includes
- 30 data tables and 20 additional tables
- A detailed overview and an up-to-date analysis of the global market for cell and tissue analysis (CTA) products and technologies
- Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Discussion of the industry growth driving factors and restraints that will shape the market for CTA products as the basis for projecting demand over the next few years (2022-2027)
- Estimation of the actual market size and revenue forecast for global cell and tissue analysis products market in USD millions, and corresponding market share analysis by type, application, end-user, and region
- Review of the commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years
- Identification of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players
- Insight into the recent industry structure, government regulations and policies, development issues, and the vendor landscape
- Information about patents and patent applications for cell and tissue analysis products and technologies by each major category
- Market share analysis of the key market participants, along with their research priorities, product portfolios, and competitive landscape
- Detailed company profiles of the leading industry players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Healthcare, Merck KGaA, PerkinElmer and Thermo Fisher Scientific Inc.
Report Scope
This report focuses on the global market of cell and tissue analysis (CTA) products and provides an updated review, including basic design and applications in various arenas of biomedical and life science research. The report deals with CTA products covering the total market, which includes three main areas of applications. These are biospecimen preparation techniques, cell separation products, and cell and tissue characterization products. These categories are further subdivided into various types. The report also covers the market for cell and tissue analysis products by end user. The end users of cell and tissue analysis products are categorized as research and academics, biopharmaceuticals, and healthcare and clinical. Excluded from this report are immunoassays.
BCC Research analyzed each market and its application, regulatory environment, new products and advancements, patent analysis, market projections, and market shares. The current report provides a detailed analysis of the market’s drivers, challenges, opportunities, and impact of COVID-19. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||
| Forecast period considered | 2022 to 2027 | ||||||||||||||||||||||||
| Base year market size | $16.7 billion | ||||||||||||||||||||||||
| Market size forecast | $28.9 billion | ||||||||||||||||||||||||
| Growth rate | CAGR of 9.6% for the forecast period of 2022-2027 | ||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||
| Segments covered | technology type, end-user, and region | ||||||||||||||||||||||||
| Regions covered | North America, Europe, Emerging markets | ||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Markets and Manufacturing Technologies for Protein Drugs (BIO021G)
- Aerospace Ceramics: Global Markets to 2029 (AVM218B)
- Digital Pathology: Technologies and Global Markets (HLC161E)
- Heat Pumps: Global Markets to 2030 (MFG090B)
- G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets (BIO136B)
Report Highlights
The global cell and tissue analysis products market reached $10.8 billion in 2015 and should reach nearly $12.5 billion by 2020, with a compound annual growth rate (CAGR) of 2.8% through 2020.
Report Highlights
The global cell and tissue analysis market was valued at $6.9 billion in 2011 and should reach $7.1 billion in 2012. Total market value is expected to reach $9.6 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 6.2%.
Report Highlights
- Overall sales in the global market of cell and tissue analysis products were worth $2.6 billion in 2008, which increased to an estimated $2.8 billion in 2009. By 2014, it is projected to increase to $4.5 billion, for a 5-year CAGR of 10.1%.
- The largest segment of the market, cell and tissue characterization products was valued at $1.2 billion in 2008; this is expected to increase to $1.3 billion in 2009, and is projected to reach $2.2 billion in 2014, for a 5-year CAGR of 10.8%.
- Sales in the cell separation products segment amounted to $1.2 billion in 2008, increased to an estimated $1.3 billion in 2009, and is projected to increase to $2.1 billion in 2014, for a 5-year CAGR of 9.8%.
Related Reports
Biosimilars: Global Markets
The global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Microscopy: The Global Market
The global market for microscopy is expected to grow from $9.7 billion in 2024 and is projected to reach $13.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2024 to 2029.
Recent Reports
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets
The global G protein-coupled receptor (GPCR) market is expected to grow from $4.4 billion in 2024 and is projected to reach $6.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
2024 Cell and Gene: Research Review
Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.
Organ-on-a-Chip: Global Markets
The global Organ-on-a-Chip market is expected to grow from $153.2 million in 2024 and is projected to reach $651.9 million by the end of 2029, at a compound annual growth rate (CAGR) of 33.6% during the forecast period of 2024 to 2029.
Single-Cell Genomics and Proteomics: Emerging Technologies and Markets
The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.
Top Trending Reports
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Global Diabetic Care Devices Market
The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.
2024 Semiconductor Manufacturing Research Review
This 2024 Research Review of the Semiconductor Manufacturing provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
2024 Medical Devices Research Review
The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More